Spotlight on: ASCO 2026
Updates from oncology’s biggest weekend
May 29 – June 2, 2026 | McCormick Place, Chicago, IL & Online
2026 ASCO Annual Meeting
Once again, pharmaphorum will be onsite at ASCO 2026, keeping you up to date on all the practice-changing new data as well as the trends and topics of discussion in Chicago. This “Spotlight On” page is your hub for ongoing coverage, including expert interviews, news bulletins, and more.
This year is shaping up to be a big one with potentially practice-changing data in lung cancer, breast cancer, prostate cancer, and more – plus some early data in cutting-edge spaces like radiotherapeutics and in vivo cell therapy.
The nation’s top oncologists will also compare notes on AI and digital tools, and we may see some interesting conversations around GLP-1s and early-onset cancer as well.
Keep this page bookmarked for news from the show as it happens, and even more analysis after the fact.
Content Highlights
🎥 ASCO 2025 insights: EVERSANA experts on AI, biomarkers, and the future of oncology
🎥Disrupting cancer cell division: How tumour treating fields are changing oncology
🎥Breaking barriers to CAR T-cell therapy: The vision for expanding patient access
၊၊||၊ Live from ASCO 2025: Boehringer Ingelheim on unmet needs and oncology innovation
Highlights from the past ASCO conferences
ASCO25 reflections: Oncology’s evolution over the last decade and a new era on the horizon
Oncology has long set the pace for biomedical innovation, but the nature of that innovation is changing. The field is shifting from a decade built on sweeping breakthroughs to one defined by nuance, complexity, and increasingly demanding strategic decisions.
ASCO25 offered a glimpse of where the field is heading. For newer entrants, the challenge lies in carving out a place within an increasingly competitive landscape, shaped by biomarker-defined subgroups and combination strategies.
Heard on the pipeline: ASCO 2024
Every year, the American Society of Clinical Oncology (ASCO) annual meeting brings together a worldwide community of innovators dedicated to advancing the frontiers of cancer research.
Amidst a wealth of knowledge and experience, pharmaphorum editor-in-chief, Jonah Comstock, was presented with a profound opportunity on the ASCO floor: the passing of the torch to the next generation of oncology experts.
About ASCO
The 2025 ASCO Annual Meeting programme will feature over 200 sessions complementing Dr Robin Zon's Presidential theme, Driving Knowledge to Action: Building a Better Future. View the official 2025 ASCO Annual Meeting programme announcement PDF for a message from the ASCO President, programme information, awards, and more.
Reported by Nicole Raleigh
Nicole Raleigh is pharmaphorum’s web editor. Transitioning to the healthcare sector in the last few years, she is an experienced media and communications professional who has worked in print and digital for over 20 years.